Xeris Biopharma Holdings, Inc. (XERS)
Nasdaq: XERS · Pharmaceutical Preparations · Chicago, IL · filing with the SEC since 2021
Who runs Xeris Biopharma Holdings, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Shannon John Patrick Jr
Chief Executive Officer and Chairman of the Board. First filing Oct 2021, latest Aug 21, 2026, 4 filings in all.
Officers reporting now
5
of 14 people with a filing in the last fifteen months
Directors reporting now
9
19 people on the record since 2021
Officerssales are open-market, Nov 6, 2025 to Nov 6, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Mcculloch Kevin | See Remarks | Aug 2024 | Nov 6, 2026 | 8 · $1.9M |
| Hecht Beth | See Remarks | Oct 2021 | Nov 4, 2026 | 14 · $1.7M |
| Pieper Steven | See Remarks | Oct 2021 | Nov 4, 2026 | 6 · $600,000 |
| Shannon John Patrick Jr | Chief Executive Officer and Chairman of the Board | Oct 2021 | Aug 21, 2026 | 2 · $300,000 |
| Nguyen Anh Tu | Chief Medical Officer | Mar 2025 | Feb 25, 2026 | none |
Directorssales are open-market, Nov 6, 2025 to Nov 6, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Taddese Menassie | director | Nov 2026 | Nov 4, 2026 | none |
| Kreher Nerissa | director | Jul 2026 | Jul 2, 2026 | none |
| Bormann-Kennedy Barbara-Jean Anne | director | Oct 2021 | Jun 5, 2026 | 2 · $200,000 |
| Brady James Aloysius | director | Mar 2025 | Jun 5, 2026 | 1 · $100,000 |
| Halkuff Dawn | director | Oct 2021 | Jun 5, 2026 | 1 · $100,000 |
| Johnson John | director | Oct 2021 | Jun 5, 2026 | 2 · $1.1M |
| Kong Garheng | director | Oct 2021 | Jun 5, 2026 | none |
| Persky Marla | director | Oct 2021 | Jun 5, 2026 | 1 · $100,000 |
| Sherman Jeffrey W | director | Oct 2021 | Aug 29, 2025 | none |
Earlier names on the record5, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.